Joël Bougaret

USPTO Granted Patents = 12 (Patent Applications = 5)

CIPO Patents = 3

EPO Patents = 6 (Patent Applications = 4)

Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 32(Granted Patents)

Location History:

Castres, FR (1992 - 1994)
Lanta, FR (2006)
Francarville, FR (2005 - 2015)

Company Filing History:

10 out of 266

Pierre Fabre Medicament

patents

2 out of 117

R.p.scherer Technologies, Inc.

patents

Years Active: 1992-2015

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9173842 - Stable pharmaceutical composition comprising a hydrosoluble vinflunine salt (2015-11-03),

2. 9061015 - Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it (2015-06-23),

3. 8476307 - Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof (2013-07-02),

4. 8304424 - Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature (2012-11-06),

5. 8124640 - Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof (2012-02-28),

6. 7658943 - Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment (2010-02-09),

7. 7595335 - Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof (2009-09-29),

8. 7338970 - Pharmaceutical composition based on a polymorphic form I of idazoxan (2008-03-04),

9. 7018648 - Transdermal device for administering testosterone or one of the derivatives thereof (2006-03-28),

10. 6890558 - Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment (2005-05-10),

11. 5334393 - Sustained-release tablet based on isosorbide 5-mononitrate and process (1994-08-02),

12. 5132116 - Tablets of the hydrophilic matrix type based on salbutamol and a process (1992-07-21),

Title: Joël Bougaret: Innovator in Pharmaceutical Composition

Introduction

Joël Bougaret is a notable inventor based in Francarville, France. He has made significant contributions to the field of pharmaceuticals, holding a total of 12 patents. His work primarily focuses on stable pharmaceutical compositions that have the potential to improve cancer treatment.

Latest Patents

Among his latest patents is a stable pharmaceutical composition comprising a hydrosoluble vinflunine salt. This composition is designed for oral administration and is preferably in the form of a capsule or tablet. The hydrosoluble vinflunine salt is identified as Vinflunine ditartrate. Another significant patent involves a stable solid dispersion of a derivative of vinca alkaloid, which relates to solid and stable dispersions of a hydrosoluble derivative of vinca alkaloids in polyethyleneglycol.

Career Highlights

Throughout his career, Joël Bougaret has worked with prominent companies in the pharmaceutical industry, including Pierre Fabre Medicament and R.P. Scherer Technologies, Inc. His expertise in developing innovative pharmaceutical solutions has made him a valuable asset in these organizations.

Collaborations

Joël has collaborated with esteemed colleagues such as Jean-Louis Avan and Elie Leverd, contributing to advancements in pharmaceutical research and development.

Conclusion

Joël Bougaret's innovative work in pharmaceutical compositions showcases his dedication to improving cancer treatment options. His numerous patents reflect his commitment to advancing medical science and enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.